Predicting kit for survival of lung cancer patients and the method of providing the information for predicting survival of lung cancer patients

The present invention relates to a kit for estimating a survival period of a lung cancer patient using composite mutant epidermal growth factor receptor (EGFR), and to a method for providing information for estimating the survival period, enabling detection of composite mutant EGFR deeply associated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HONG, JI YOUNG, YOUN, JONG PIL, HWANG, SEUNG YONG, CHANG, YOON SOO, KIM, EUN YOUNG, LIM, SE RI
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a kit for estimating a survival period of a lung cancer patient using composite mutant epidermal growth factor receptor (EGFR), and to a method for providing information for estimating the survival period, enabling detection of composite mutant EGFR deeply associated with the survival period of the lung cancer patient in a relatively precise and easy way. Thus, it is possible to prepare treatment plans by precisely estimating the prognosis of the lung cancer showing the highest mortality rates among other types of cancer. 본 발명은 상피세포성장인자 수용체(Epidermal Growth Factor Receptor, EGFR) 복합 돌연변이를 이용한 폐암 환자의 생존기간 예측용 키트와 생존기간 예측을 위한 정보 제공 방법에 관한 것이다. 본 발명은 폐암 환자의 생존기간과 깊게 연관된 EGFR 복합 돌연변이를 비교적 정확하고 용이하게 검출할 수 있도록 한다. 이로써, 본 발명은 현재 암 사망의 주요 원인에 해당하는 폐암 환자의 예후를 보다 정확하게 예측하여 그에 따른 치료적 대비가 가능하도록 한다.